The NeurologyLive Features page houses all of our feature-length explorations into the trending topics that affect patient care and disease management in neurology, featuring the voices of key opinion leaders in the field.
Support, Skepticism, and Statistics: The Aducanumab Saga
After a sudden reversal and complex analyses, aducanumab’s future rests in the hands of the FDA while the community stands split on if the available data are enough to justify an approval.